About Us


Discovery-Insight provides independent consulting advice on all aspects of drug discovery and early development, specifically to Phase IIb clinical proof of principle. With more than 24 years of Pharmaceutical and Biopharmaceutical research and development experience, founder and principal, Graeme Martin Ph.D., offers established expertise in:

  • Drug discovery and development portfolio strategic management
  • Clinical development through IND submission to Phase IIb
  • Diligence associated with product / technology licensing and partnering opportunities

A specialist in the CNS therapy area, Dr. Martin also has extensive experience in the management of discovery and development in the pain, cardiovascular, respiratory and urogenital therapy areas.Replica Rolex Clients include major financial institutions, multinational Pharmaceutical companies, Biopharmaceutical companies and entrepreneurs in the USA and in Europe.

Although an independent consulting operation, Discovery-Insight is directly and indirectly affiliated with consultants, academic institutions and contract research organizations in both the USA and the United Kingdom. Consequently we are well positioned to identify expert support for all aspects of drug development through IND submission and beyond. Discovery-Insight can also assist with the organization and conduct of Phase I clinical studies in Europe, often enabling critical development decisions to be made faster and in a more cost-effective manner.

[Home] [About Us] [Services] [Links] [News]

Please contact our Webmaster with questions or comments.